Antioxidants inhibit the ability of lysophosphatidylcholine to regulate proteoglycan synthesis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 3, 2006, Pages 494-500

  Chang, Mary Y ^a   Han, Chang Yeop ^a   Wight, Thomas N ^b   Chait, Alan ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b HOPE HEART INSTITUTE   (United States)

Author keywords

Antioxidants; Catalase; Lysophosphatidylcholine; PG MCSF; Proteoglycans; Reactive oxygen species; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; CATALASE; CELL PROTEIN; FLUORESCENT DYE; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; LYSOPHOSPHATIDYLCHOLINE; PROPIDIUM IODIDE; PROTEOGLYCAN; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOTOXICITY; ENZYME RELEASE; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GEL MOBILITY SHIFT ASSAY; MACACA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIOXIDANTS; CATALASE; CELLS, CULTURED; DRUG INTERACTIONS; FREE RADICAL SCAVENGERS; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES; MACACA NEMESTRINA; MUSCLE, SMOOTH, VASCULAR; PROTEOGLYCANS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 33646590330     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000200135.61362.27     Document Type: Article

References (37)

1. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995;15:551-561.
2. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radical Biology and Medicine. 1996;20:707-727.
3. Witztum JL. The role of oxidized LDL in the atherogenic process. J Arterioscler Thromb. 1994;1:71-75.
4. Chang MY, Potter-Perigo S, Tsoi C, Chait A, Wight TN. Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties. J Biol Chem. 2000;275:4766-4773.
5. Chang MY, Tsoi C, Wight TN, Chait A. Lysophosphatidylcholine regulates synthesis of biglycan and the proteoglycan form of macrophage colony stimulating factor. Arterioscler Thromb Vasc Biol. 2003;23:809-815.
6. Murugesan G, Fox PL. Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein. J Clin Invest. 1996;97:2736-2744.
7. Subbaiah PV, Chen CH, Bagdade JD, Albers JJ. Substrate specificity of plasma lysolecithin acyltransferase and the molecular species of lecithin formed by the reaction. J Biol Chem. 1985;260:5308-5314.
8. Portman OW, Alexander M. Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J Lipid Res. 1969;10:158-165.
9. Wight TN. Biosynthesis of Proteoglycans. In: Pinto BM, ed. Comprehensive Natural Products Chemistry. Amsterdam: Elsevier Science Ltd; 1999.
10. Camejo G, Fager G, Rosengren B, Hurt-Camejo E, Bondjers G. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem. 1993;268:14131-14137.
11. Cardoso LE, Mourao PA. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. J Biol Chem. 1994;258:9086-9092.
12. Goldberg IJ, Wagner WD, Pang L, Paka L, Curtiss LK, DeLozier JA, Shelness GS, Young CSH, Pillarisetti S. The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans. J Biol Chem. 1998;273:35355-35361.
13. O'Brien KD, Olin KL, Alpers CE, Chiu W, Ferguson M, Hudkins K, Wight TN, Chait A. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation. 1998;98:519-527.
14. Olin KL, Potter-Perigo S, Barrett HR, Wight TN, Chait A. Lipoprotein lipase enhances the binding of native oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells. Journal of Biological Chemistry. 1999;274:34629-34636.
15. Chang MY, Olin KL, Tsoi C, Wight TN, Chait A. Human monocyte-derived macrophages secrete two forms of proteoglycan-macrophage colony stimulating factor (PG-MCSF) that differ in their ability to bind low density lipoproteins. J Biol Chem. 1998;273:15985-15992.
16. Suzu S, Inaba T, Yanai N, Kawashima T, Yamada N, Oka T, Machinami R, Ohtsuki T, Kimura F, Kondo S. Proteoglycan form of macrophage colony-stimulating factor binds low density lipoprotein. J Clin Invest. 1994;94:1637-1641.
17. Finkel T. Reactive oxygen species and signal transduction. IUBMB Life. 2001;52:3-6.
18. Schonherr E, Jarvelainen HT, Sandell LJ, Wight TN. Effects of platelet-derived growth factor and transforming growth factor, beta1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem. 1991;66:17640-17647.
19. Fleischmajer R, Fisher LW, MacDonald ED, Jacobs LJ, Perlish JS, Termine JD. Decorin interacts with fibrillar collagen of embryonic and adult human skin. J Struct Biol. 1991;106:82-90.
20. Partenheimer A, Schwarz K, Wrocklage C, Kolsch E, Kresse H. Proteoglycan form of colony-stimulating factor-1 (proteoglycan-100). Stimulation of activity by glycosaminoglycan removal and proteolytic processing. J Immunol. 1995;155:5557-5565.
21. LeBaron RG, Zimmermann DR, Ruoslahti E. Hyaluronate binding properties of versican. J Biol Chem. 1992;267:10003-10010.
22. Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, Rigoni A, Pastorino AM, Lo Cascio V, Sawamura T. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem. 2000;275:12633-12638.
23. Myhre O, Andersen JM, Aarnes H, Fonnum F. Evaluation of the probes 2′,7′-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem Pharmacol. 2003;65:1575-1582.
24. Keller A, Mohamed A, Drose S, Brandt U, Fleming I, Brandes RP. Analysis of dichlorodihydrofluorescein and dihydrocalcein as probes for the detection of intracellular reactive oxygen species. Free Radic Res. 2004;38:1257-1267.
25. Heinecke JW, Baker L, Rosen H, Chait A. Superoxide-mediated free radical modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest. 1986;77:757-761.
26. Brown BG, Zhao X-Q, Sacco DE, Albers JJ. Atherosclerosis regression, plaque disruption, and cardiovascular events: A rationale for lipid lowering in coronary artery disease. Ann Rev Med. 1993;44:365-376.
27. Muller J, Petkovic M, Schiller J, Arnold K, Reichl S, Arnhold J. Effects of lysophospholipids on the generation of reactive oxygen species by fMLP- and PMA-stimulated human neutrophils. Luminescence. 2002;17:141-149.
28. Wolfram Kuhlmann CR, Wiebke Ludders D, Schaefer CA, Kerstin Most A, Backenkohler U, Neumann T, Tillmanns H, Erdogan A. Lysophosphatidylcholine- induced modulation of Ca(2+)-activated K(+)channels contributes to ROS-dependent proliferation of cultured human endothelial cells. J Mol Cell Cardiol. 2004;36:675-682.
29. Yamakawa T, Tanaka S, Yamakawa Y, Kamei J, Numaguchi K, Motley ED, Inagami T, Eguchi S. Lysophosphatidylcholine activates extracellular signal-regulated kinases 1/2 through reactive oxygen species in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2002;22:752-758.
30. Nieto N, Friedman SL, Cederbaum AI. Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis by hepatic stellate cells. J Biol Chem. 2002;277:9853-9864.
31. Moseley R, Waddington RJ, Embery G, Rees SG. The modification of alveolar bone proteoglycans by reactive oxygen species in vitro. Connect Tissue Res. 1998;37:13-28.
32. Cardoso L, Maurao PAS. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma low density lipoprotein. Arterioscler Thromb. 1994;14:115-124.
33. Weltzien HU. Cytolytic and membrane-perturbing properties of lysophosphatidycholine. Biochim Biophys Acta. 1979;559:259-287.
34. Takeda A, Palfree R, Forsdyke D. Role of serum in inhibition of cultured lymphocytes by lysophosphatidylcholine. Biochemica et Biophysica Acta. 1982;710:87-98.
35. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science. 1995;270:296-299.
36. Beckman JS, Minor RL, Jr., White CW, Repine JE, Rosen GM, Freeman BA. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J Biol Chem. 1988;263:6884-6892.
37. Nakamura T, Lin L-L, Kharbanda S, Knopf J, Kufe D. Macrophage colony stimulating factor activates phosphatidylcholine hydrolysis by cytoplasmic phospholipase A2. EMBO J. 1992;11:4917-4922.